Phosphorothioates, Essential Components of Therapeutic Oligonucleotides

Cited by (687)

Items 301–400 of 687

1. Synthesis and Evaluation of Neutral Phosphate Triester Backbone-Modified siRNAs
   Kouta Tsubaki, Matthew L. Hammill, Andrew Varley, Mitsuru Kitamura, Tatsuo Okauchi, Jean‐Paul Desaulniers · 2020 · ACS Medicinal Chemistry Letters
2. Nanobiotechnology-Enabled mRNA Stabilization
   He Xian, Yue Zhang, Chengzhong Yu, Yue Wang · 2023 · Pharmaceutics
3. Ion-Pairing Hydrophilic Interaction Chromatography for Impurity Profiling of Therapeutic Phosphorothioated Oligonucleotides
   Luca Tutiš, Paul Ferguson, David Benstead, Adrian M. Clarke, Carl Heatherington, Chris Gripton, Christina Jayne Vanhinsbergh, Govert W. Somsen, Andrea Gargano · 2025 · Analytical Chemistry
4. Detection of intracellular sodium ions based on phenotype-specific activation of NaA43 DNAzyme
   Lok Ting Chu, Hoi Kwan Kwong, Hogi Hartanto, Ting‐Hsuan Chen · 2022 · Biosensors and Bioelectronics
5. Phosphorothioate RNA Analysis by NETD Tandem Mass Spectrometry
   Trenton M. Peters-Clarke, Qiuwen Quan, Benton J. Anderson, William M. McGee, Emily Lohr, Alexander S. Hebert, Michael S. Westphall, Joshua J. Coon · 2024 · Molecular & Cellular Proteomics
6. Application of Modified Antisense Oligonucleotides and Sirnas as Antiviral Drugs
   Anke Wagner, C.–Thomas Bock, Henry Fechner, Jens Kurreck · 2015 · Future Medicinal Chemistry
7. Chemical Development of Therapeutic Oligonucleotides
   Karin E. Lundin, Olof Gissberg, C. I. Edvard Smith, Rula Zain · 2019 · Methods in molecular biology
8. The role of Nucleic Acid Mimics (NAMs) on FISH-based techniques and applications for microbial detection
   Montserrat Nachér-Vázquez, Bruno F. R. Santos, Nuno F. Azevedo, Laura Cerqueira · 2022 · Microbiological Research
9. Oligonucleotide-Based Therapies for Inflammatory Bowel Disease
   Gerolamo Bevivino, Silvia Sedda, Irene Marafini, Giovanni Monteleone · 2018 · BioDrugs
10. Tips for Successful lncRNA Knockdown Using Gapmers
    Kim A. Lennox, Mark A. Behlke · 2020 · Methods in molecular biology
11. Therapeutic applications of RNA nanostructures
    Theresa Yip, Xiaodong Qi, Hao Yan, Yung Chang · 2024 · RSC Advances
12. Phosphorothioate-DNA bacterial diet reduces the ROS levels in C. elegans while improving locomotion and longevity
    Qiang Huang, Ruohan Li, Tao Yi, Fengsong Cong, Dayong Wang, Zixin Deng, Yi‐Lei Zhao · 2021 · Communications Biology
13. Design and fabrication of intracellular therapeutic cargo delivery systems based on nanomaterials: current status and future perspectives
    Hong Ma, Fei Xing, Yuxi Zhou, Peiyun Yu, Rong Luo, Jiawei Xu, Zhou Xiang, Pol Maria Rommens, Xin Duan, Ulrike Ritz · 2023 · Journal of Materials Chemistry B
14. Transcription factors in the development and treatment of immune disorders
    Samantha D. Drinan, Juan I. Fuxman Bass, Juan I. Fuxman Bass · 2023 · Transcription
15. Sequence- and Structure-Dependent Cytotoxicity of Phosphorothioate and 2′- O -Methyl Modified Single-Stranded Oligonucleotides
    Laura V. Croft, Mark Fisher, Tabassum Khair Barbhuiya, Serene El‐Kamand, Samuel Beard, Aleksandra Rajapakse, Roland Gamsjaeger, Liza Cubeddu, Emma Bolderson, Kenneth John O'Byrne et al. · 2024 · Nucleic Acid Therapeutics
16. In vivo efficacy and safety of systemically administered serinol nucleic acid-modified antisense oligonucleotides in mouse kidney
    Toshiki Tsuboi, Keita Hattori, Takuji Ishimoto, Kentaro Imai, Tomohito Doke, Junichiro Hagita, Jumpei Ariyoshi, Kazuhiro Furuhashi, Noritoshi Kato, Yasuhiko Ito et al. · 2024 · Molecular Therapy — Nucleic Acids
17. Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease
    Kevin A. Lidberg, Andrew J. Annalora, Marija Jozic, Daniel J. Elson, Lu Wang, Theo K. Bammler, Susanne Ramm, Maria Beatriz Monteiro, Jonathan Himmelfarb, Craig B. Marcus et al. · 2021 · Scientific Reports
18. Chemical Modification and Transformation Strategies of Guide RNAs in CRISPR‐Cas9 Gene Editing Systems
    Yu Zhang, Qian Wang, Jing Wang, Xinjing Tang · 2021 · ChemPlusChem
19. Preclinical and Clinical Drug-metabolism, Pharmacokinetics and Safety of Therapeutic Oligonucleotides
    Patrik Urban Andersson, Cathaline den Besten · 2019 · Royal Society of Chemistry eBooks
20. A simple and highly efficient method for multi‐allelic CRISPR‐Cas9 editing in primary cell cultures
    Pia Hoellerbauer, Megan Kufeld, Sonali Arora, Hua‐Jun Wu, Heather M. Feldman, Patrick J. Paddison · 2020 · Cancer Reports
21. Advances and Strategies in Enhancing mRNA Cancer Vaccines
    Miao Zhang, Shengqi Chen, Hai-Jun Hu, Yenhui Ong, Qianqian Ni · 2025 · Advanced Materials
22. An overview of structural approaches to study therapeutic RNAs
    Luca Mollica, Francesca Anna Cupaioli, Grazisa Rossetti, Federica Chiappori · 2022 · Frontiers in Molecular Biosciences
23. Progress of cGAS-STING signaling pathway-based modulation of immune response by traditional Chinese medicine in clinical diseases
    Hui Zhi, Hui Fu, Yunxin Zhang, Ni Fan, Chengcheng Zhao, Yunfei Li, Yujiao Sun, Yingpeng Li · 2024 · Frontiers in Immunology
24. Efficient Multi‐Allelic Genome Editing of Primary Cell Cultures via CRISPR‐Cas9 Ribonucleoprotein Nucleofection
    Pia Hoellerbauer, Megan Kufeld, Patrick J. Paddison · 2020 · Current Protocols in Stem Cell Biology
25. Delivery strategies for RNA-targeting therapeutic nucleic acids and RNA-based vaccines against respiratory RNA viruses: IAV, SARS-CoV-2, RSV
    Kinga Maziec, Agnieszka Baliga-Gil, Elżbieta Kierzek · 2025 · Molecular Therapy — Nucleic Acids
26. Artificial intelligence in the development of small nucleic acid therapeutics: toward smarter and safer medicines
    Pietro Delre, Carmen Cerchia, Antonio Lavecchia · 2025 · Drug Discovery Today
27. Investigation of Sequence‐Penetration Relationships of Antisense Oligonucleotides
    Nefeli Batistatou, Joshua A. Kritzer · 2023 · ChemBioChem
28. Cellular Export Fate of Liposomal Spherical Nucleic Acids
    Krishna S. Paranandi, Andrew Lee, Nikola Stanic, Chad Alexander Mirkin · 2023 · ACS Nano
29. Recent advances in living cell nucleic acid probes based on nanomaterials for early cancer diagnosis
    Xuyao Liu, Qi Shi, Peng Qi, Ziming Wang, Tongyue Zhang, Sijia Zhang, Jiayan Wu, Zhaopei Guo, Jie Chen, Qiang Zhang · 2024 · Asian Journal of Pharmaceutical Sciences
30. Bioanalytical Assays for Oligonucleotide Therapeutics: Adding Antibody-Based Immunoassays to the Toolbox as an Orthogonal Approach to LC-MS/MS and Ligand Binding Assays
    David P. Chimento, Amy L. Anderson, Inês Fial, Carl A. Ascoli · 2025 · Nucleic Acid Therapeutics
31. Antisense RNA therapies for muscular dystrophies
    Virginia Arechavala‐Gomeza, Andrea López‐Martínez, Annemieke M Aartsma-Rus · 2025 · Journal of Neuromuscular Diseases
32. Simultaneous Targeting of Multiple oncomiRs with Phosphorothioate or PNA-Based Anti-miRs in Lymphoma Cell Lines
    Karishma Dhuri, Sai Pallavi Pradeep, Jason Shi, Eleni Anastasiadou, Frank John Slack, Anisha Gupta, Xiao‐bo Zhong, Raman Bahal · 2022 · Pharmaceutical Research
33. Propensities of Fatty Acid-Modified ASOs: Self-Assembly vs Albumin Binding
    Eric-André Kusznir, Jean-Christophe Hau, Michaela Portmann, Anne-Gaëlle Reinhart, Fabio Falivene, Jessica Bastien, Jesper Worm, Alfred Ross, Matthias E. Lauer, Philippe Ringler et al. · 2023 · Bioconjugate Chemistry
34. Establishing stereochemical comparability in phosphorothioate oligonucleotides with nuclease P1 digestion coupled with LCMS analysis
    Zifan Li, Fei Tong, Xiao Li, Nicholas R. Larson, Xuan Zhou, Yueheng Zhang, Jonas P. Immel‐Brown, George M. Bou-Assaf · 2023 · The Analyst
35. Nuclease stability of boron-modified nucleic acids: application to label-free mismatch detection
    Maëva Reverte, Jean‐Jacques Vasseur, Michaël Smietana · 2015 · Organic & Biomolecular Chemistry
36. Effects of phosphodiester and phosphorothioate ODN2216 on leukotriene synthesis in human neutrophils and neutrophil apoptosis
    Galina M. Viryasova, Ekaterina A. Golenkina, Svetlana I. Galkina, Tatjana V. Gaponova, Yulia M. Romanova, Galina F. Sud’ina · 2016 · Biochimie
37. Artificial nucleic acid backbones and their applications in therapeutics, synthetic biology and biotechnology
    Sven Epple, Afaf Helmy El-Sagheer, Tom Brown · 2021 · Emerging Topics in Life Sciences
38. NanoSIMS Imaging Reveals the Impact of Ligand-ASO Conjugate Stability on ASO Subcellular Distribution
    Emma I. Kay, Rouven Stulz, Cécile Becquart, Jelena Lovrić, Carolina Tängemo, Aurélien Thomen, Dženita Baždarević, Neda Najafinobar, Anders Dahlén, Anna Pielach et al. · 2022 · Pharmaceutics
39. Structure-activity relationship study of mesyl and busyl phosphoramidate antisense oligonucleotides for unaided and PSMA-mediated uptake into prostate cancer cells
    Olga V. Sergeeva, E.A. Akhmetova, Svetlana Dukova, Elena Kimovna Beloglazkina, Anastasia A. Uspenskaya, Aleksei E. Machulkin, Dmitry A. Stetsenko, Timofei S. Zatsepin · 2024 · Frontiers in Chemistry
40. Progress in Tandem Mass Spectrometry Data Analysis for Nucleic Acids
    Michael B. Lanzillotti, Jennifer S. Brodbelt · 2025 · Mass Spectrometry Reviews
41. Cyanobacterial Argonautes and Cas4 family nucleases cooperate to interfere with invading DNA
    Pilar Bobadilla Ugarte, Stefanie Halter, Sumanth Kumar Mutte, Clint Heijstek, Théophile Niault, Ilya M. Terenin, Patrick Barendse, Balwina Koopal, Mark Roosjen, Sjef A. Boeren et al. · 2025 · Molecular Cell
42. Rise and fall of fomivirsen, the first approved gene silencing medicine : A historical review
    Miklós Bege, Anikó Borbás · 2022 · Acta Pharmaceutica Hungarica
43. Chemical synthesis of RNA with site-specific methylphosphonate modifications
    Sara Flür, Ronald Micura · 2016 · Methods
44. 4′-C-Trifluoromethyl modified oligodeoxynucleotides: synthesis, biochemical studies, and cellular uptake properties
    Yifei Zhou, Chuanlong Zang, Huawei Wang, Jiajun Li, Zenghui Cui, Qiang Li, Fengmin Guo, Zhiguo Yan, Xin Wen, Zhen Xi et al. · 2019 · Organic & Biomolecular Chemistry
45. Reprint of: Non Canonical Genetic Material
    Elena Eremeeva, Piet A. Herdewijn · 2019 · Current Opinion in Biotechnology
46. Identification of a Tricyclic P III Chiral Auxiliary for Solid‐Supported Synthesis of Stereopure Phosphorothioate‐Containing Oligonucleotides
    Sukumar Sakamuri, Dingguo Liu, Laxman Eltepu, Bin Liu, Lisa Jo Reboton, Ryan Preston, Curt W. Bradshaw · 2019 · ChemBioChem
47. Nucleic acid therapeutics in neurodevelopmental disease
    Audrey M. Winkelsas, Kenneth H. Fischbeck · 2020 · Current Opinion in Genetics & Development
48. Small nucleic acids and the path to the clinic for anti-CRISPR
    Christopher L. Barkau, Daniel O’Reilly, Seth B. Eddington, Masad José Damha, Keith T. Gagnon · 2021 · Biochemical Pharmacology
49. 7′,5′-alpha-bicyclo-DNA: new chemistry for oligonucleotide exon splicing modulation therapy
    Damien Evéquoz, Ingrid E.C. Verhaart, Davy van de Vijver, Wolfgang A. Renner, Annemieke M Aartsma-Rus, Christian J. Leumann · 2021 · Nucleic Acids Research
50. Status and Prospects of Aptamers as Drug Components
    Christopher Mattice, Maria C. DeRosa · 2015 · BioDrugs
51. Synthesis and biological evaluation of sialyl-oligonucleotide conjugates targeting leukocyte B trans-membranal receptor CD22 as delivery agents for nucleic acid drugs
    Gabrielle St‐Pierre, Sudip Pal, Michael E. Østergaard, Tianyuan Zhou, Jinghua Yu, Michael Tanowitz, Punit P. Seth, Stephen Hanessian · 2016 · Bioorganic & Medicinal Chemistry
52. Current Status of Antisense Oligonucleotide-Based Therapy in Neuromuscular Disorders
    Flavien Bizot, Adeline Vulin, Aurélie Goyenvalle · 2020 · Drugs
53. Bioconjugates for improved delivery of oligonucleotide therapeutics to the central nervous system
    Hye Jin Lee, Yunxuan Xie, Colin F. Greineder, Peter M. Tessier · 2026 · Advanced Drug Delivery Reviews
54. Smad7 Antisense Oligonucleotide in Crohn’s Disease: A Re-Evaluation and Explanation for the Discordant Results of Clinical Trials
    Giovanni Monteleone, Carmine Stolfi · 2022 · Pharmaceutics
55. Enhancement of in vivo targeting properties of ErbB2 aptamer by chemical modification
    Jun Young Park, Ye Lim Cho, Ju Ri Chae, Jung Hwan Lee, Won Jun Kang · 2023 · PLoS ONE
56. Peptide Conjugates of a 2′-O-Methoxyethyl Phosphorothioate Splice-Switching Oligonucleotide Show Increased Entrapment in Endosomes
    Alyssa C. Hill, Jan Philipp Becker, Daria Slominski, François Halloy, Christoffer Soendergaard, Jacob Ravn, Jonathan Hall · 2023 · ACS Omega
57. A High-Throughput Workflow for Mass Spectrometry Analysis of Nucleic Acids by Nanoflow Desalting
    Michael B. Lanzillotti, Jennifer S. Brodbelt · 2024 · Analytical Chemistry
58. Understanding Antisense Oligonucleotide Efficiency in Inhibiting Prokaryotic Gene Expression
    Sandra Story, Sayantan Bhaduri, Sudakshina Ganguly, Rambabu Dakarapu, Sarah L. Wicks, Jhuma Bhadra, Simeon Owuor Kwange, Dev P. Arya · 2024 · ACS Infectious Diseases
59. Potential of Cell-Penetrating Peptide-Conjugated Antisense Oligonucleotides for the Treatment of SMA
    Jamie Leckie, Toshifumi Yokota · 2024 · Molecules
60. Quantitative Analysis of Phosphorothioate Isomers in CRISPR sgRNA at Single-Residue Resolution Using Endonuclease Digestion Coupled with Liquid Chromatography Cyclic Ion Mobility Mass Spectrometry (LC/cIMS)
    Yue Su, Bo Zhao, Liang Zhang, Biao Shen, Chunguang Guo, Hui Xiao, Ning Li · 2025 · Analytical Chemistry
61. Enhanced Control of Liposomal Drug Release by Drug–Aptamer Complexes
    Xiangang Huang, Yang Li, Matthew Torre, Rachelle Shao, Wei Zhang, Zihan Wang, Daniel S. Kohane, Christopher Bertero Weldon · 2025 · Advanced Materials
62. Application of Nucleic Acid Mimics in Fluorescence In Situ Hybridization
    Ricardo Oliveira, Andreia Sofia Azevedo, Luzia Mendes · 2021 · Methods in molecular biology
63. SiRNAs with Neutral Phosphate Triester Hydrocarbon Tails Exhibit Carrier-Free Gene-Silencing Activity
    Matthew L. Hammill, Kouta Tsubaki, Lidya Salim, Andrew Varley, Ifrodet Giorgees, Mitsuru Kitamura, Tatsuo Okauchi, Jean‐Paul Desaulniers · 2022 · ACS Medicinal Chemistry Letters
64. Next-Generation Peptide Nucleic Acid Chimeras Exhibit High Affinity and Potent Gene Silencing
    Alexandre J. Debacker, Vivek K. Sharma, Pranathi Meda Krishnamurthy, Daniel O’Reilly, Rachel Greenhill, Jonathan K. Watts · 2018 · Biochemistry
65. Potent and Selective Knockdown of Tyrosine Kinase 2 by Antisense Oligonucleotides
    Nhan van Tran, Le Tuan Anh Nguyen, Kah Wai Lim, Anh Tuân Phan · 2021 · ImmunoHorizons
66. A Convenient Oligonucleotide Conjugation via Tandem Staudinger Reaction and Amide Bond Formation at the Internucleotidic Phosphate Position
    Kristina Klabenkova, Polina V. Zhdanova, Ekaterina A. Burakova, S.N. Bizyaev, А. А. Фокина, Dmitry A. Stetsenko · 2024 · International Journal of Molecular Sciences
67. Integrating Machine Learning-Based Approaches into the Design of ASO Therapies
    Jamie Leckie, Toshifumi Yokota · 2025 · Genes
68. Acute neuronal inhibition response caused by phosphorothioate antisense oligonucleotides following local delivery to the central nervous system
    Jacqueline G O’Rourke, Gemma Bachmann, Curt Mazur, Keming Zhou, Oleksandr Platoshyn, Mariana Bravo Hernández, Stephanie K. Klein, Jonathon Nguyen, Sebastien A. Burel, Christine M. Hoffmaster et al. · 2025 · Nucleic Acids Research
69. Gene Regulation Using Nanodiscs Modified with HIF-1-α Antisense Oligonucleotides
    Radhika Sharma, Yixiao Dong, Yuesong Hu, Victor Pui-Yan Ma, Khalid S. Salaita · 2022 · Bioconjugate Chemistry
70. Lipid nanoparticle-encapsulated, chemically modified anti-adenoviral siRNAs inhibit hepatic adenovirus infection in immunosuppressed Syrian hamsters
    Anja Geisler, Babette Dieringer, Leslie Elsner, Karin Klingel, Robert Klopfleisch, Hans‐Peter Vornlocher, Jens Kurreck, Henry Fechner · 2023 · Molecular Therapy — Nucleic Acids
71. Nucleic Acid-Based Approaches to Tackle KRAS Mutant Cancers
    Jimi Kim · 2023 · International Journal of Molecular Sciences
72. The separation of cyclic diadenosine diphosphorothioate and the diastereomers of its difluorinated derivative and the estimation of the binding constants and ionic mobilities of their complexes with 2‐hydroxypropyl‐β‐cyclodextrin by affinity capillary electrophoresis
    Sille Štěpánová, Petra Břehová, Václav Kašička · 2024 · Electrophoresis
73. Light-Activated Nanodiamond-Based Drug Delivery Systems for Spatiotemporal Release of Antisense Oligonucleotides
    Hoi Man Leung, Ling Sum Liu, Yuzhen Cai, Xinru Li, Yizhi Huang, Hoi Ching Chu, Y. Rebecca Chin, Pik Kwan Lo · 2024 · Bioconjugate Chemistry
74. Synthesis and Properties of Oligonucleotides Containing LNA-Sulfamate and Sulfamide Backbone Linkages
    Belma Zengin Kurt, Debashis Dhara, Afaf Helmy El-Sagheer, Tom P Brown · 2024 · Organic Letters
75. Structural dynamics of therapeutic nucleic acids with phosphorothioate backbone modifications
    Antonio Carlesso, Johanna Hörberg, Giuseppe Deganutti, Anna Reymer, Pär Matsson · 2024 · NAR Genomics and Bioinformatics
76. In What Ways Do Synthetic Nucleotides and Natural Base Lesions Alter the Structural Stability of G-Quadruplex Nucleic Acids?
    János Sági · 2017 · Journal of Nucleic Acids
77. Systematic editing of synthetic RIG-I ligands to produce effective antiviral and anti-tumor RNA immunotherapies
    Jang Hyun Lee, Eun-Byeol Park, Jiyoun Min, Si-Eun Sung, Yejin Jang, Jin Soo Shin, Dongmin Chun, Kihun Kim, Jihyun Hwang, Mi‐Kyung Lee et al. · 2018 · Nucleic Acids Research · Retracted
78. 34S: A New Opportunity for the Efficient Synthesis of Stable Isotope Labeled Compounds
    Sumei Ren, Patrick S. Fier, Hong Ren, Andrew J. Hoover, David Hesk, Rosemary Marques, Ingrid Mergelsberg · 2018 · Chemistry - A European Journal
79. A Versatile and Convenient Synthesis of 34S‐Labeled Phosphorothioate Oligonucleotides
    Rouven Stulz, Johan Meuller, Dženita Baždarević, Charlotte Wennberg Huldt, Roger Strömberg, Shalini Andersson, Anders Dahlén · 2018 · ChemBioChem
80. Bacterial Epigenomics: Epigenetics in the Age of Population Genomics
    Poyin Chen, DJ Darwin R. Bandoy, Bart C. Weimer · 2020 · Springer eBooks
81. Hepatitis D virus (HDV): investigational therapeutic agents in clinical trials
    Bilal Asif, Christopher Koh · 2021 · Expert Opinion on Investigational Drugs
82. Nonclinical Exon Skipping Studies with 2′- O -Methyl Phosphorothioate Antisense Oligonucleotides in mdx and mdx-utrn−/− Mice Inspired by Clinical Trial Results
    Maaike van Putten, C. Tanganyika-de Winter, Sieto Bosgra, Annemieke M Aartsma-Rus · 2019 · Nucleic Acid Therapeutics
83. Post-SELEX modifications with locked nucleic acids (LNA) of a SEA-specific DNA aptamer assisted by in silico modelling
    Ricardo Oliveira, Eva Pinho, Nuno F. Azevedo, Carina Almeida · 2024 · Molecular Systems Design & Engineering
84. Exploring the diagnostic landscape: Portable aptasensors in point-of-care testing
    Anu Mohan, Ipsita Roy · 2025 · Analytical Biochemistry
85. Next generation APOBEC3 inhibitors: optimally designed for potency and nuclease stability
    Adam K. Hedger, Wazo Myint, Jeong Min Lee, Diego Suchenski Loustaunau, Vanivilasini Balachandran, Ala M. Shaqra, Neşe Kurt Yılmaz, Jonathan K. Watts, Hiroshi Matsuo, Celia A. Schiffer · 2025 · Nucleic Acids Research
86. Y-shaped DNA as a dynamic self-assembly nanomaterial for phenotype-specific regulation of stem cell differentiation on the gene level
    Wengang Liu, Ruili Liu, Lok Ting Chu, Xinlei Wang, Jianpeng Wu, Jiandong Ding, Ting‐Hsuan Chen · 2025 · Regenerative Biomaterials
87. A CRISPR/Cas9 screen reveals proteins at the endosome-Golgi interface that modulate cellular anti-sense oligonucleotide activity
    Liza Malong, Jessica Roskosch, Carolina Hager, Jean‐Philippe Fortin, Roland Schmucki, Marinella G. Callow, Christian Weile, Valentina Romeo, Christoph Patsch, Scott E. Martin et al. · 2025 · Nature Communications
88. Characterization of Escherichia coli RNase H Discrimination of DNA Phosphorothioate Stereoisomers
    Lukasz Jan Kielpinski, Erik Daa Funder, Steffen Schmidt, Peter Hagedorn · 2021 · Nucleic Acid Therapeutics
89. Triazole-linked Nucleic Acids: Synthesis, Therapeutics and Synthetic Biology Applications
    Vivek K. Sharma, Priyanka Mangla, Sunil Kumar Singh, Ashok Kumar Prasad · 2023 · Current Organic Synthesis
90. Degradation of Toxic RNA in Myotonic Dystrophy Using Gapmer Antisense Oligonucleotides
    Quynh Nguyen, Toshifumi Yokota · 2020 · Methods in molecular biology
91. Incorporating a Thiophosphate Modification into a Common RNA Tetraloop Motif Causes an Unanticipated Stability Boost
    Pradeep S. Pallan, Terry P. Lybrand, Mark K. Schlegel, Joel M. Harp, Hartmut Jahns, Muthiah Manoharan, Martin Egli · 2020 · Biochemistry
92. Sequence determination of phosphorothioated oligonucleotides using MALDI‐TOF mass spectrometry for controlling gene doping in equestrian sports
    Teruaki Tozaki, Ho-Geun Kwak, Kotono NAKAMURA, Masaki Takasu, Hideaki Ishii, Aoi Ohnuma, Mio Kikuchi, Taichiro Ishige, Hironaga Kakoi, Kei-ichi HIROTA et al. · 2021 · Drug Testing and Analysis
93. A rapid nucleic acid detection platform based on phosphorothioate-DNA and sulfur binding domain
    Yuting Shuai, Yi Ju, Yuanhang Li, Dini Ma, Lan Jiang, Jingyu Zhang, Gao‐Yi Tan, Xueting Liu, Shenlin Wang, Lixin Zhang et al. · 2023 · Synthetic and Systems Biotechnology
94. The Medicinal Chemistry of Antisense Oligonucleotides
    Jonathan K. Watts · 2018 · Wiley eBooks
95. Phosphatidylcholine head group chemistry alters the extrahepatic accumulation of lipid-conjugated siRNA
    Vignesh Narayan Hariharan, Takahiro Nakamura, Minwook Shin, Qi Tang, Vyankat A. Sontakke, Jillian Caiazzi, Samuel R. Hildebrand, Anastasia Khvorova, Ken Yamada · 2024 · Molecular Therapy — Nucleic Acids
96. Chemical Modifications in Nucleic Acid Therapeutics
    Kim A. Lennox, Rebecca C. Young, Mark A. Behlke · 2025 · Methods in molecular biology
97. General Approach for the Synthesis of Triazinyl Phosphoramidate Oligonucleotides via the Staudinger Reaction with the Use of 2-Azido-4,6-dichloro-1,3,5-triazine
    Timofey D. Zharkov, Maxim S. Kupryushkin · 2025 · ACS Omega
98. Unraveling and controlling late-onset neurotoxicity of antisense oligonucleotides through strategic chemical modifications
    Takayuki Kuroda, Kotaro Yoshioka, Su Su Lei Mon, Maho Katsuyama, Kumiko Sato, Eriko Isogai, Kie Yoshida‐Tanaka, Rintaro Iwata-Hara, Takao Yamaguchi, Satoshi Obika et al. · 2025 · Molecular Therapy — Nucleic Acids
99. A modified X10-23 DNAzyme that can better access large, structured RNA targets
    Connor Nurmi, Halle M. Barber, Harneesh Kaur, John D. Brennan, Masad José Damha, Yingfu Li · 2025 · Nucleic Acids Research
100. Synthesis of Chimeric Oligonucleotides Having Modified Internucleotide Linkages via an Automated H‐Phosphonate/Phosphoramidite Approach
     Danielle Vlaho, Masad José Damha · 2018 · Current Protocols in Nucleic Acid Chemistry